Basosquamous carcinoma (BSC) is a rare, biologically aggressive tumor. This cross‐sectional study aims to define risk factors for subclinical nodal metastasis in primary BSC, and identify the patients who would… Click to show full abstract
Basosquamous carcinoma (BSC) is a rare, biologically aggressive tumor. This cross‐sectional study aims to define risk factors for subclinical nodal metastasis in primary BSC, and identify the patients who would benefit from routine sentinel node biopsy (SLNB) as part of the initial management.
               
Click one of the above tabs to view related content.